People
Matt Del Rosso
Biography
Matt has over a decade of experience advising banks, financial institutions and private credit funds, with an emphasis on private equity and corporate driven leveraged finance.
Based in our Singapore office since 2015, Matt has advised on some of the largest and most complex leveraged financing transactions in the region, and has built a reputation among market participants as one of the Asia-Pacific’s leading lender-side leveraged finance lawyers.
Matt’s practice also covers a broad base of other structured finance transactions, including NAV and subscription-line financing, margin financing, project financing and investment grade lending, typically involving multiple jurisdictions.
Known for his technical ability, commercial awareness and in-depth understanding of the jurisdictions in which his clients operate, Matt is considered to be a trusted legal advisor to some of the most influential financial institutions across South and South-East Asia.
Practice areas
- Leveraged finance
- Investment grade debt
- Project development and finance
- Private equity
- Leveraged finance and high yield
Sectors
- Energy
- Banks
- Mining and metals
- Private capital
- Private equity
- Private credit
Selected experience
- The mandated lead arrangers and bookrunners on the debt financing for the Adani Group’s US$10.5 billion acquisition of Ambuja Cements Limited (NSE: AMBUJACEM) and ACC Limited (NSE: ACC) in India. This is India’s largest ever M&A transaction in the infrastructure and materials space, and has been recognized by numerous publications, including as Deal of the Year, India in the India Business Law Journal, and Loan Deal of the Year by IFLR.
- The mandated lead arrangers in relation to financing the acquisition by PT Asianet Media Teknologi (a portfolio company of I Squared Capital) of a fibre optic network in Indonesia from PT MNC Kabel Mediacom.
- The mandated lead arrangers in relation to the debt financing for Advent International’s acquisition of Suven Pharmaceuticals (NSE: SUVENPHAR), a leading Indian listed pharmaceuticals company.
- The mandated lead arrangers and bookrunners in relation to the debt financing for Blackstone’s US$570 million acquisition of International Gemological Institute in India, a global leader in the independent certification of diamonds.
- A global financial institution in relation to the debt financing for Frontier Tower Associates’ (a portfolio company of KKR) acquisition of 3,539 telecom towers from Globe Telecom in the Philippines. This was a landmark transaction for private equity backed infrastructure acquisitions in the Philippines, and was recognized as Debt Market Deal of the Year by ALB Philippines, 2023.
- The mandated lead arrangers and bookrunners in relation to the debt financing for KKR’s US$460 million acquisition of a controlling stake in J.B. Chemicals & Pharmaceuticals (NSE: JBCHEPHARM) in India. This transaction was one of the largest control deals in Asia at the time, and was awarded Private Equity Deal of the Year by IFLR, 2021.
- The mandated lead arrangers and bookrunners in relation to the debt financing for Baring Private Equity Asia’s (now EQT) US$1.2 billion acquisition of Hinduja Global Solutions Limited’s healthcare services business (now Sagility), covering business process management operations in India, the Philippines, the US and Jamaica.
- The mandated lead arrangers in relation to the bridge financing arrangements for San Miguel Corporation’s US$1.6 billion acquisition of Eagle Cement in the Philippines.
- The mandated lead arrangers and bookrunners in relation to the debt financing for Gulf Energy Development’s US$5.4 billion public leveraged buyout of Intouch Holdings. This was the largest leveraged buyout in Asia for 2021, and was the second largest leveraged buyout ever done in Thailand.
- The mandated lead arrangers and bookrunners in relation to the financing for the US1$ billion acquisition by Baring Private Equity Asia (now EQT) of CitiusTech Healthcare Technology Private Limited in India, a provider of consulting and digital technology to healthcare and life sciences companies.
Education
- LLB (Distinction), The University of Western Australia, 2012
- BSc, Pharmacology, The University of Western Australia, 2012
- Graduate Diploma of Legal Practice, The Australian National University, 2013
Admissions
- England & Wales, 2024
- Western Australia, 2013
Languages
- English
